AAN GUIDELINES Bundle

AAN PDN 2021 eviewer

AAN GUIDELINES Product Bundle brought to you by Guideline Central.

Issue link: https://eguideline.guidelinecentral.com/i/1499275

Contents of this Issue

Navigation

Page 4 of 5

Treatment Figure 1. Class Effects for the Most Well-Studied Oral Treatments of Painful Diabetic Polyneuropathy e effects of different oral medication classes on painful diabetic neuropathy including gabapentinoids, serotonin-norepinephrine reuptake inhibitors (SNRIs), sodium channel blockers, SNRI/opioid dual mechanism agents, and tricyclic antidepressants (TCAs).

Articles in this issue

view archives of AAN GUIDELINES Bundle - AAN PDN 2021 eviewer